A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 5, 2006, Pages 353-361

  Siesky, Brent ^a   Harris, Alon ^a   Sines, Daniel ^a   Rechtman, Ehud ^a   Malinovsky, Victor E ^b   McCranor, Lynne ^a   Yung, Chi Wah ^a   Zalish, Miriam ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL; TIMOLOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOROID; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FORMULATION; EYE BLOOD FLOW; EYE FUNDUS; FEMALE; FIXED DRUG COMBINATION; HEART RATE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; KIDNEY DISEASE; LASER DOPPLER FLOWMETRY; LASER FLOWMETER; LIVER DISEASE; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RETINA; RETINA ARTERY; SCANNING LASER OPHTHALMOSCOPY; SYSTOLE; VISION; VISUAL ACUITY;

ADRENERGIC BETA-ANTAGONISTS; AGED; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EYE; FEMALE; GLAUCOMA, OPEN-ANGLE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSTAGLANDINS F, SYNTHETIC; REGIONAL BLOOD FLOW; SULFONAMIDES; THIOPHENES; TIMOLOL; VISUAL ACUITY;

EID: 33750717258     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.353     Document Type: Article

References (50)

1. Rojanapongpun, P., Drance, S.M., and Morrison, B.J. Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br. J. Ophthalmol. 77(1):25-29, 1993.
2. Butt, Z., McKillop, G., O'Brien, C., et al. Measurement of ocular blood flow velocity using colour Doppler imaging in low tension glaucoma. Eye 9(Pt 1):29-33, 1995.
3. Leighton, D.A., and Phillips, C.I. Systemic blood pressure in open-angle glaucoma, low-tension glaucoma, and the normal eye. Br. J. Ophthalmol. 56(6):447-453, 1972.
4. Hayreh, S.S., Zimmerman, M.B., Podhajsky, P., et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am. J. Ophthalmol. 117(5):603-624, 1994.
5. Drance, S., Anderson, D.R., and Schulzer, M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am. J. Ophthalmol. 131(6):699-708, 2001.
6. Harris, A., Harris, M., Biller, J., et al. Aging affects the retrobulbar circulation differently in females and males. Arch. Ophthalmol. 118(8):1076-1080, 2000.
7. Harris, A., Arend, O., Kagemann, L., et al. Dorzolamide, visual function, and ocular haemodynamics in normal-tension glaucoma. J. Ocul. Pharmacol. Ther. 15(3):189-197, 1999.
8. Harris, A., Sergott, R.C., Spaeth, G.L., et al. Colour Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am. J. Ophthalmol. 118(5):642-649, 1994.
9. Breil, P., Krummenauer, F., Schmitz, S., et al. The relationship between retrobulbar blood flow velocity and glaucoma damage. [German] Ophthalmologe 99(8):613-616, 2002.
10. Harris, A., Jonescu-Cuypers, C.P., Kagemann, L., et al. Simultaneous management of blood flow in glaucoma. Acta. Ophthalmol. Scand. 79(4):336-341, 2001.
11. Sherbini, M.E., Gekkieva, M., Flammer, J., et al. Effect of Xalatan® and Cosopt® on the vascular tone of quiescent isolated pig ciliary arteries. Klinische Monatsblatter fur Augenheilkunde 219(4):273-226, 2002.
12. Srjernschantz, J., Nilsson, S.F., and Astin, M. Vasodynamic and angiogenic effects of eicosanoids in the eye. Prog. Clin. Biol. Res. 312:155-170, 1989.
13. Sugrue, M., Harris, A., and Adamsons, I. Dorzolamide hydrochloride: A topically active, carbonic anhydrase inhibitor for the treatment of glaucoma. Drugs Today 33:283-298, 1997.
14. Taki, K., Kato, H., Endo, S., et al. Cascade of acetazol-amide-induced vasodilatation. Res. Comm. Mol. Path Pharmacol. 103(3):240-248, 1999.
15. Maren, T.H. Basic science in clinical glaucoma-the development of topical carbonic anhydrase inhibitors. J. Glaucoma 4:49-62, 1995.
16. Petropoulos, I.K., Pournaras, J.A., Munoz, J.L., et al. Effect of acetazolamide on the optic disc oxygenation in miniature pigs. Klinische Monatsblatter fur Augenheilkunde 221(5):367-370, 2004.
17. Dallinger, S., Bobr, B., Findl, O., et al. Effects of acetazolamide on choroidal blood flow. Stroke 29(5):997-1001, 1998.
18. Harris, A., Arend, O., Arend, S., et al. Effects of topical dorzolamide on retinal and retrobulbar hemodynamics. Acta. Ophthalmol. Scand. 74(6):569-572, 1996.
19. Martinez, A., Gonzalez, F., Capeans, C., et al. Dorzolamide effect on ocular blood flow. Invest. Opthalmol. Vis. Sci. 40(6):1270-1275, 1999.
20. Calugaru, M., and Calugaru, D. Timolol topical ophthalmic combination. [Review: Romanian] Oftalmologia 48(1):5-14, 2004.
21. Harris, A., and Martin, B. Beta-blockers and ocular blood flow: A perspective. J. Glaucoma 6(3):143-145, 1997.
22. Kagemann, L., Harris, A., Chung, H.S., et al. Heidelberg Retinal Flowmetry. Factors affecting blood flow measurement. Br. J. Ophthalmol. 82(2):131-136, 1998.
23. Jonescu-Cuypers, C.P., Harris, A., Wilson, R., et al. Reproducibility of the Heidelberg Retinal Flowmeter in determining low perfusion areas in peripapillary retina. Br. J. Ophthalmol. 88(10):1266-1269, 2004.
24. Yu, D.Y., Townsend, R., Cringle, S.J., et al. Improved interpretation of flow maps obtained by scanning laser Doppler flowmetry using a rat model of retinal artery occlusion. Invest. Ophthalmol. Vis. Sci. 46(1):166-174, 2005.
25. Jonescu-Cuypers, C.P., Harris, A., Bartz-Schmidt, K.U., et al. Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg Retinal Flowmetry. Br. J. Ophthalmol. 88(3):348-353, 2004.
26. Harris, A., Kagemann, L., Chung, H.S., et al. The use of dye dilution curve analysis in the indocyanine green angiograms of the human choroid. Ophthalmol. Clin. N. Am.: Ophthalmic Imag. Diagnost. 11(3):331-337, 1998.
27. Williamson, T.H., and Harris, A. Color Doppler ultrasound imaging of the eye and orbit. Surv. Ophthalmol. 40(4):255-267, 1996.
28. Harris, A., Williamson, T., Martin, B., et al. Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J. Glaucoma 4:281-286, 1995.
29. Fechtner, R.D., Airaksinen, P.J., Getson, A.J., et al. COSOPT versus XALATAN Study Groups. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: Results from two randomized, clinical trials. Acta. Ophthalmol. Scand. 82(1):42-48, 2004.
30. Schmidt, K.G., von Ruckmann, A., Becker, R., et al. [Ocular pulse amplitude, intraocular pressure, and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma]. [German] Klinische Monatsblatter fur Augenheilkunde 215(6):361-366, 1999.
31. Harris, A., Arend, O., Chung, H.S., et al. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal tension glaucoma patients. Ophthalmology 107(3):430-434, 2000.
32. Arend, O., Harris, A., Wolter, P., et al. Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol, and latanoprost in newly diagnosed open-angle glaucoma patients. Acta. Ophthalmol. Scand. 81(5):474-479, 2003.
33. Harris, A., Arend, O., Arend, S., et al. Effects of topical dorzolamide on retinal and retrobulbar haemodynamics. Acta. Ophthalmol. Scand. 74(6)569-572, 1996.
34. Josefsson, A., Sigurdsson, S.B., Bang, K., et al. Dorzolamide induces vasodilatation in isolated pre-contracted bovine retina arteries. Exp. Eye Res. 78:215-221, 2004.
35. Bernd, A.S., Pillunat, L.E., Bohm, A.G., et al. [Ocular hemodynamics and visual field in glaucoma treated with dorzolamide.] [German] Ophthalmologe 98(5):451-455, 2001.
36. Schmidt, K.G., von Ruckmann, A., Becker, R., et al. [Ocular pulse amplitude, intraocular pressure, and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma]. [German] Klinische Monatsblatter fur Augenheilkunde 215(6):361-366, 1999.
37. Schmidt, K.G., Dick, B., von Ruckmann, A., et al. [Ocular pulse amplitude and local carbonic anhydrase inhibition]. [German] Ophthalmologe 94(9):659-664, 1997.
38. Martinez, A., Gonzalez, F., Capeans, C., et al. Dorzolamide effect on ocular blood flow. Invest. Ophtalmol. Vis. Sci. 40(6):1270-1275, 1999.
39. Herkel, U., and Pfeiffer, N. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors]. [German] Ophthalmologe 98(10):929-933, 2001.
40. Bergstrand, I.C., Heijl, A., and Harris, A. Dorzolamide and ocular blood flow in previously untreated glaucoma patients: A controlled, double-masked study. Acta. Ophthalmol. Scand. 80(2):176-182, 2002.
41. Pillunat, L.E., Bohm, A.G., Koller, A.U., et al. Effect of topical dorzolamide on optic nerve head blood flow. Graefe's Arch. Clin. Exp. Ophthalmol. 237(6):495-500, 1999.
42. Grunwald, J.E., Mathur, S., and DuPont, J. Effects of dorzolamide hydrochloride 2% on the retinal circulation. Acta. Ophthalmol. Scand. 75(3):236-238, 1997.
43. Orge, F., Harris, A., Kagemann, L., et al. The first technique for noninvasive measurements of volumetric ophthalmic artery blood flow in humans. Br. J. Ophthalmol. 86(11):1216-1219, 2002.
44. Georgopoulos, G., Diestelhorst, M., Fisher, R., et al. The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta. Ophthalmol. Scand. 80(1)54-58, 2002.
45. Januleviciene, I., Harris, A., Kagemann, L., et al. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients. Acta. Ophthalmol. Scand. 82(6):730-773, 2004.
46. Inan, U.U., Ermis, S.S., Yucel, A., et al. The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: A 3-month clinical trial. Acta. Ophthalmol. Scand. 81(2):155-160, 2003.
47. Akarsu, C., Bilgili, Y.K., Taner, P., et al. Short-term effect of latanoprost on ocular circulation in ocular hypertension. Clin. Exp. Ophthalmol. 32(4):373-377, 2004.
48. Harris, A., Migliardi, R., Rechtman, E., et al. Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. Eur. J. Ophthalmol. 13(1):24-31, 2003.
49. Petropoulos, I.K., Pournaras, J.A., Munoz, J.L., et al. Effect of acetazolamide on the optic disc oxygenation in miniature pigs. Klinische Monatsblatter fur Augenheilkunde 221(5):367-370, 2004.
50. Pedersen, D.B., Jensen, P.K., la Cour, M., et al. Carbonic anhydrase inhibitors increased retinal oxygen tension and dilates retinal vessels. Graefe's Arch. Clin. Exp. Ophthalmol. 243(2):163-168, 2005.